ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,950, issued on May 20, was assigned to MOMENTA PHARMACEUTICALS INC. (Titusville, N.J.).
"Methods of producing ustekinumab" was invented by Ru Zang (Auburndale, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of manufacturing an ustekinumab product with a target level of one or more glycans are described."
The patent was filed on Dec. 20, 2019, under Application No. 17/419,480.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12304950&OS=12304950&RS=12304950
Disclaimer:...